Chemtrade Q2 2026 earnings jump as lower finance costs offset weaker electrochemicals margins, company says

• For Q2 2026, revenue rose 16.5% to CAD 578.7 million, driven by Polytec and higher merchant acid, sulphur products, Regen acid pricing.
• Adjusted EBITDA fell 7.8% to CAD 127.3 million, pressured by lower chlor-alkali pricing, weaker sodium chlorate volumes, higher input costs.
• Net earnings climbed to CAD 42.9 million from CAD 9.7 million, helped by lower finance costs and prior-year impairment.
• Operating cash flow increased to CAD 91.9 million from CAD 85.1 million, reflecting working-capital inflows despite lower EBITDA.
• Distributable cash after maintenance capex dropped 40.7% to CAD 42.4 million, hit by higher maintenance spending and softer EBITDA.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemtrade Logistics Income Fund published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.